Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome
- PMID: 24320036
- DOI: 10.2174/1381612819666131206103102
Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome
Abstract
Resistin is an adipocyte- and monocyte-derived cytokine which has been implicated in the modulation of insulin action, energy, glucose and lipid homeostasis. Resistin has been associated with insulin resistance and many of its known complications. As a molecular link between metabolic signals, inflammation, and vascular dysfunction, resistin can be proposed as playing a significant role in the heightened inflammatory state induced by metabolic stress linked to excessive caloric intake, thus contributing to the risk for metabolic syndrome (MetS), type 2 diabetes (T2DM), and cardiovascular diseases (CVD). In this review, we highlighted the role of resistin, as an inflammatory cytokine, in the development of CVD, T2DM and the MetS.
Similar articles
-
Evidence for the involvement of resistin in inflammation and cardiovascular disease.Curr Diabetes Rev. 2005 Aug;1(3):227-34. doi: 10.2174/157339905774574392. Curr Diabetes Rev. 2005. PMID: 18220599 Review.
-
Role of resistin in obesity, insulin resistance and Type II diabetes.Clin Sci (Lond). 2005 Sep;109(3):243-56. doi: 10.1042/CS20050078. Clin Sci (Lond). 2005. PMID: 16104844 Review.
-
Linking resistin, inflammation, and cardiometabolic diseases.Korean J Intern Med. 2017 Mar;32(2):239-247. doi: 10.3904/kjim.2016.229. Epub 2017 Feb 16. Korean J Intern Med. 2017. PMID: 28192887 Free PMC article. Review.
-
[Resistin: a pathogenic factor or a biomarker of metabolic disorders and inflammation?].Postepy Hig Med Dosw (Online). 2009 Oct 23;63:485-91. Postepy Hig Med Dosw (Online). 2009. PMID: 19940327 Review. Polish.
-
Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro-inflammatory cytokines.J Cell Physiol. 2019 Dec;234(12):21758-21769. doi: 10.1002/jcp.28913. Epub 2019 Jun 11. J Cell Physiol. 2019. PMID: 31187484 Review.
Cited by
-
Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus.BMJ Open Diabetes Res Care. 2020 Sep;8(1):e001206. doi: 10.1136/bmjdrc-2020-001206. BMJ Open Diabetes Res Care. 2020. PMID: 32988848 Free PMC article.
-
The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review.BMC Endocr Disord. 2022 Aug 31;22(1):217. doi: 10.1186/s12902-022-01135-y. BMC Endocr Disord. 2022. PMID: 36045354 Free PMC article.
-
Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis.J Am Heart Assoc. 2016 Sep 28;5(10):e003845. doi: 10.1161/JAHA.116.003845. J Am Heart Assoc. 2016. PMID: 27680666 Free PMC article.
-
Prospective Association of Circulating Adipokines with Cardiometabolic Risk Profile Among Women: The Rape Impact Cohort Evaluation Study.Womens Health Rep (New Rochelle). 2022 Oct 7;3(1):820-833. doi: 10.1089/whr.2022.0069. eCollection 2022. Womens Health Rep (New Rochelle). 2022. PMID: 36340478 Free PMC article.
-
Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus.Compr Physiol. 2018 Dec 13;9(1):1-58. doi: 10.1002/cphy.c170040. Compr Physiol. 2018. PMID: 30549014 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials